カテゴリ： GlobalData, 企業調査, 日本

Otsuka Holdings Co Ltd (4578)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Otsuka Holdings Co Ltd (4578) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C11408
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：85
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：日本
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Otsuka Holdings Co Ltd (Otsuka) is a holding company, which operates various businesses such as pharmaceuticals, nutraceuticals, consumer products and other businesses through its subsidiaries. It focuses on the research and development, manufacture, and sale of medicines for the treatment of cancer, cardiovascular diseases, central nervous system disorders, ophthalmic diseases, gastrointestinal and respiratory diseases, infectious diseases, dermatological conditions and allergies. The company’s product portfolio includes pharmaceutical products, cosmetics, functional foods and beverages, alcoholic beverages, fine chemicals, electronic equipment, functional chemicals, medical devices and OTC products. It markets its products in North America, Europe and Asia. Otsuka is headquartered in Chiyoda-ku, Tokyo, Japan.

Otsuka Holdings Co Ltd (4578) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Otsuka Holdings Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Otsuka Holdings Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Otsuka Holdings Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Otsuka Holdings Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
Otsuka Holdings Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Otsuka Holdings Co Ltd, Medical Equipment, Deal Details 14
Venture Financing 14
Promaxo Raises USD2.2 Million in Second Tranche of Series A Financing 14
Megakaryon Raises USD9.7 Million in Series C Financing 15
Science 37 Raises USD35 Million in Series C Financing 17
Promaxo Raises USD3.5 Million in First Tranche of Series A Venture financing 19
Zenomics Raises USD5.8 Million in Financing 20
ReCor Medical Raises USD10 Million in Venture Financing 21
ReCor Medical Raises USD15 Million in Series D Financing 22
Proteus Digital Health Raises US$63 Million In Series F Financing Round 23
Private Equity 24
MicroPort Scientific and Yunfeng Capital Acquire Cardiac Rhythm Management Business from LivaNova For USD190 Million 24
Partnerships 26
Otsuka Pharma and Proteus Digital Health Enter into Collaboration Agreement 26
Safe Orthopedics Signs Partnership Agreement with KiSCO 27
Science 37 Enters into Agreement with Otsuka Pharma 28
MicroPort Scientific to Enter into Distribution Agreement with Promaxo 29
Shanghai MicroPort Enters into Agreement with Wiltrom 30
Lombard Medical Enters into Co-Marketing Agreement with MicroPort Scientific 31
MicroPort Scientific Enters into Agreement with MinInvasive 32
Otsuka Enters into Agreement with ReCor Medical 33
Otsuka Medical and UriCare Form Joint Venture 34
Lilium Otsuka, UriCare and AIST Enter into R&D and Marketing Agreement 35
Shanghai MicroPort Partners with Second Military Medical University 36
MicroPort Scientific Forms Joint Venture with Sorin 37
ReFlow Medical Enters Into Distribution Agreement With MicroPort Scientific 38
Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 39
Response Genetics Extends Agreement With Taiho Pharma For Molecular Markers 41
C2N Diagnostics Enters Into Research Agreement With Cambridge Isotope Labs For Biomarkers 42
Gavis Pharma Partners with Nichiban 43
Otsuka Medical Enters Into Co-Development Agreement With Pioneer For Medical Endoscope 44
MicroPort Medical Forms Joint Venture With MicroPort Endovascular 45
NuView Life Sciences Enters into Licensing Agreement with Otsuka Pharma for VPAC1 Biomarker 46
Proteus Biomedical Enters Into Licensing Agreement With Otsuka Pharma 47
Equity Offering 48
MinInvasive Raises Funds through Private Placement of Shares 48
Otsuka Invests in ReCor Medical 49
Debt Offering 50
MicroPort Scientific Raises USD100 Million in Private Placement of Bonds Due 2019 50
Acquisition 51
Otsuka Holdings to Acquire Remaining Stake in ReCor Medical from Sofinnova Partners 51
Otsuka Pharma Acquires Lilium Otsuka from Otsuka Medical Devices 52
Otsuka Pharmaceutical Factory to Acquire Remaining 20% Stake in Otsuka Pharmaceutical India from Mitsui 53
Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 54
Egypt Otsuka Pharmaceutical to Acquire 80% Stake in Ateco Pharma 55
MicroPort Scientific Plans To Acquire Medical Device Company 56
MicroPort Acquires D-Pulse Medical 57
MicroPort Scientific Acquires Winning Forward For US$5.3 Million 58
MicroPort Medical Acquires Dongguan Kewei Medical From Savernake Investments For Up To US$17 Million 59
Otsuka Holdings Co Ltd – Key Competitors 60
Otsuka Holdings Co Ltd – Key Employees 61
Otsuka Holdings Co Ltd – Locations And Subsidiaries 62
Head Office 62
Other Locations & Subsidiaries 62
Recent Developments 65
Strategy And Business Planning 65
Oct 15, 2018: Otsuka expands digital medicines alliance with Proteus Digital 65
Financial Announcements 66
Aug 08, 2018: Otsuka Holdings reports consolidated financial results for the second quarter of the fiscal year ending December 31, 2018 66
Feb 14, 2018: Otsuka Holdings announces Consolidated Financial Results for the Fiscal Year Ended December 31, 2017 73
Nov 14, 2017: Otsuka Holdings: Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending December 31, 2017 76
May 12, 2017: Otsuka Holdings Company Reports Net Sales Of JPY280.2 Billion In Q1 2017 78
Feb 14, 2017: Otsuka Holdings Company Reports Net Sales Of JPY1.2 Trillion In 2016 79
Corporate Communications 80
Mar 29, 2018: Otsuka Holdings appoints board members and audit & supervisory board members 80
Feb 14, 2018: Otsuka Holdings Announces Personnel Changes 81
Mar 30, 2017: Otsuka Holdings appoints Board Members and Audit & Supervisory Board Members 83
Feb 14, 2017: Otsuka Holdings Announces Personnel Changes 84
Appendix 85
Methodology 85
About GlobalData 85
Contact Us 85
Disclaimer 85

List of Tables
Otsuka Holdings Co Ltd, Medical Equipment, Key Facts, 2017 2
Otsuka Holdings Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Otsuka Holdings Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Otsuka Holdings Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Otsuka Holdings Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Otsuka Holdings Co Ltd, Deals By Market, 2012 to YTD 2018 10
Otsuka Holdings Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Promaxo Raises USD2.2 Million in Second Tranche of Series A Financing 14
Megakaryon Raises USD9.7 Million in Series C Financing 15
Science 37 Raises USD35 Million in Series C Financing 17
Promaxo Raises USD3.5 Million in First Tranche of Series A Venture financing 19
Zenomics Raises USD5.8 Million in Financing 20
ReCor Medical Raises USD10 Million in Venture Financing 21
ReCor Medical Raises USD15 Million in Series D Financing 22
Proteus Digital Health Raises US$63 Million In Series F Financing Round 23
MicroPort Scientific and Yunfeng Capital Acquire Cardiac Rhythm Management Business from LivaNova For USD190 Million 24
Otsuka Pharma and Proteus Digital Health Enter into Collaboration Agreement 26
Safe Orthopedics Signs Partnership Agreement with KiSCO 27
Science 37 Enters into Agreement with Otsuka Pharma 28
MicroPort Scientific to Enter into Distribution Agreement with Promaxo 29
Shanghai MicroPort Enters into Agreement with Wiltrom 30
Lombard Medical Enters into Co-Marketing Agreement with MicroPort Scientific 31
MicroPort Scientific Enters into Agreement with MinInvasive 32
Otsuka Enters into Agreement with ReCor Medical 33
Otsuka Medical and UriCare Form Joint Venture 34
Lilium Otsuka, UriCare and AIST Enter into R&D and Marketing Agreement 35
Shanghai MicroPort Partners with Second Military Medical University 36
MicroPort Scientific Forms Joint Venture with Sorin 37
ReFlow Medical Enters Into Distribution Agreement With MicroPort Scientific 38
Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 39
Response Genetics Extends Agreement With Taiho Pharma For Molecular Markers 41
C2N Diagnostics Enters Into Research Agreement With Cambridge Isotope Labs For Biomarkers 42
Gavis Pharma Partners with Nichiban 43
Otsuka Medical Enters Into Co-Development Agreement With Pioneer For Medical Endoscope 44
MicroPort Medical Forms Joint Venture With MicroPort Endovascular 45
NuView Life Sciences Enters into Licensing Agreement with Otsuka Pharma for VPAC1 Biomarker 46
Proteus Biomedical Enters Into Licensing Agreement With Otsuka Pharma 47
MinInvasive Raises Funds through Private Placement of Shares 48
Otsuka Invests in ReCor Medical 49
MicroPort Scientific Raises USD100 Million in Private Placement of Bonds Due 2019 50
Otsuka Holdings to Acquire Remaining Stake in ReCor Medical from Sofinnova Partners 51
Otsuka Pharma Acquires Lilium Otsuka from Otsuka Medical Devices 52
Otsuka Pharmaceutical Factory to Acquire Remaining 20% Stake in Otsuka Pharmaceutical India from Mitsui 53
Otsuka Pharma to Acquire 50% Stake in Diatranz Otsuka from Living Cell Technologies for USD3 Million 54
Egypt Otsuka Pharmaceutical to Acquire 80% Stake in Ateco Pharma 55
MicroPort Scientific Plans To Acquire Medical Device Company 56
MicroPort Acquires D-Pulse Medical 57
MicroPort Scientific Acquires Winning Forward For US$5.3 Million 58
MicroPort Medical Acquires Dongguan Kewei Medical From Savernake Investments For Up To US$17 Million 59
Otsuka Holdings Co Ltd, Key Competitors 60
Otsuka Holdings Co Ltd, Key Employees 61
Otsuka Holdings Co Ltd, Subsidiaries 62

List of Figures
Otsuka Holdings Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Otsuka Holdings Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Otsuka Holdings Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Otsuka Holdings Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Otsuka Holdings Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Otsuka Holdings Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
Otsuka Holdings Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Otsuka Holdings Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

★海外企業調査レポート[Otsuka Holdings Co Ltd (4578)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Seminole Electric Cooperative, Inc.：発電所・企業SWOT分析
    Seminole Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Flex Ltd (FLEX)：企業の財務・戦略的SWOT分析
    Flex Ltd (FLEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • mixi, Inc.：企業の戦略・SWOT・財務分析
    mixi, Inc. - Strategy, SWOT and Corporate Finance Report Summary mixi, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Brunei LNG Sdn Bhd：企業の戦略的SWOT分析
    Brunei LNG Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Saga plc：企業の戦略・SWOT・財務情報
    Saga plc - Strategy, SWOT and Corporate Finance Report Summary Saga plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Siemens AG：企業の戦略・SWOT・財務情報
    Siemens AG - Strategy, SWOT and Corporate Finance Report Summary Siemens AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Brodrene Hartmann AS：戦略・SWOT・企業財務分析
    Brodrene Hartmann AS - Strategy, SWOT and Corporate Finance Report Summary Brodrene Hartmann AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Digirad Corp (DRAD)-医療機器分野：企業M&A・提携分析
    Summary Digirad Corp (Digirad) is a medical device company that offers mobile and on-site imaging solutions. The company offers camera products which include ergo, cardius x-ACT, cardius 2 XPO, corcam, quantumcam, and cardius 3 XPO. Its diagnostic services include nuclear cardiology, ultrasound, neu …
  • Milestone Scientific Inc (MLSS)：企業の財務・戦略的SWOT分析
    Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments in the medical and dental fields. The company’s medical specialties include anesthesiology, pain medicine, orthopedic surgery, …
  • Bharat Heavy Electricals Ltd (BHEL)：企業の財務・戦略的SWOT分析
    Bharat Heavy Electricals Ltd (BHEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Chimerix Inc (CMRX)：企業の財務・戦略的SWOT分析
    Summary Chimerix Inc (Chimerix) is a biopharmaceutical company that develops, discovers, and commercializes novel and oral antiviral therapeutics. The company’s brincidofovir is an oral nucleotide analog to treat dsDNA viruses, adenovirus, cytomegalovirus, BK virus and herpes simplex viruses. Chimer …
  • Kokuyo Camlin Ltd (KOKUYOCMLN)：企業の財務・戦略的SWOT分析
    Kokuyo Camlin Ltd (KOKUYOCMLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • LCC International, Inc.：企業の戦略的SWOT分析
    LCC International, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Diebold Nixdorf, Incorporated：戦略・SWOT・企業財務分析
    Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Advance Auto Parts, Inc.：企業の戦略・SWOT・財務分析
    Advance Auto Parts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Advance Auto Parts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AJ Lucas Group Ltd (AJL)：企業の財務・戦略的SWOT分析
    AJ Lucas Group Ltd (AJL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CMC Biologics AS：製薬・医療：M&Aディール及び事業提携情報
    Summary CMC Biologics A/S (CMC Biologics), formerly CMC Biopharmaceuticals A/S, a subsidiary of Asahi Glass Co., Ltd., is a contract process development and manufacturer of biopharmaceuticals. The company's service portfolio encompasses process development, cGMP manufacturing, and quality and regula …
  • Nikon Corporation：企業の戦略・SWOT・財務情報
    Nikon Corporation - Strategy, SWOT and Corporate Finance Report Summary Nikon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Oxford Nanopore Technologies Ltd-医療機器分野：企業M&A・提携分析
    Summary Oxford Nanopore Technologies Ltd (Oxford Nanopore), formerly Oxford NanoLabs Ltd., is a biotechnology diagnostic company. It develops technologies for molecular detection and analysis. The company offers a range of nanopores and devices such as MinION, PromethION and GridION used for the ana …
  • Jardine Lloyd Thompson Group plc：企業のM&A・事業提携・投資動向
    Jardine Lloyd Thompson Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Jardine Lloyd Thompson Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆